September 23, 2024

Muscle Relaxants: Limited Long-Term Benefit for Pain

Despite doubling of muscle relaxant prescriptions since 2005, new review finds limited evidence for long-term benefit in most chronic pain conditions.

Conexiant

September 13, 2024

Current MRI Definitions Miss Knee OA Risk

A recent study found that current magnetic resonance imaging definitions of knee osteoarthritis may not reliably predict the onset of symptomatic or radiographic knee OA over an 11-year follow-up.

Conexiant

May 22, 2024

Krill Oil for Knee Pain?

Clinical trial reveals krill oil's lack of efficacy in treating knee pain for osteoarthritis patients.

Conexiant

June 11, 2024

Omega-3 Supplementation and Its Effects on Osteoarthritis

Omega-3 supplementation has shown potential in reducing inflammation and improving symptoms in osteoarthritis, though further research is needed to confirm its efficacy.

Conexiant

July 10, 2024

OA Linked to Higher Multimorbidity Risk, Study

A 20-year study reveals that patients with osteoarthritis have a higher risk of severe multimorbidity, emphasizing the need for comprehensive health care strategies beyond joint health.

Conexiant

July 26, 2024

EHR Use Disparities: Female vs. Male Surgeons

A recent study published in JAMA Network Open reveals gender differences in electronic health record (EHR) usage among surgeons, with female surgeons writing significantly longer progress notes than their male counterparts.

Conexiant

July 26, 2024

Healing and Owing: U.S. Health Workers' $150 Billion Debt Dilemma

A new study exposes the alarming levels of medical and educational debt burdening U.S. health care workers, with debt disproportionately affecting women, Black workers, and those in lower-paying fields.

Conexiant

August 14, 2024

U.S. Adults’ Exposure to 6 Potentially Hepatotoxic Botanicals

A recent study found that approximately 15.6 million U.S. adults may be using botanicals with known liver toxicity, raising concerns about potential hepatotoxic risks and the lack of regulatory oversight.

Conexiant

April 30, 2024

Allocation of NIH Funding to Musculoskeletal Disease Research Is Lacking

Although musculoskeletal diseases are prevalent among the U.S. population, National Institutes of Health (NIH) funding assigned to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) may be low compared with other institutes.

Conexiant